NDFOS Co. Ltd Net Assets
NDFOS Co. Ltd net assets. Based on the latest financial reports, NDFOS Co. Ltd (238090) has net assets worth ₩96.69 Billion KRW (≈ $65.52 Million USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₩111.51 Billion ≈ $75.57 Million USD) and total liabilities (₩14.82 Billion ≈ $10.04 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore how fast is NDFOS Co. Ltd growing its equity to track the company's year-over-year net asset growth rate.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ₩96.69 Billion |
| % of Total Assets | 86.71% |
| Annual Growth Rate | 22.94% |
| 5-Year Change | -32.3% |
| 10-Year Change | 268.72% |
| Growth Volatility | 74.07 |
Net Assets of NDFOS Co. Ltd (2014–2024)
Net assets of NDFOS Co. Ltd from 2014 to 2024. This chart illustrates how NDFOS Co. Ltd's net assets have evolved over time, based on quarterly financial data. See how leveraged is NDFOS Co. Ltd's balance sheet to measure how much of total assets are equity-financed.
Annual Net Assets for NDFOS Co. Ltd (2014–2024)
The table below shows the annual net assets of NDFOS Co. Ltd from 2014 to 2024. For live market cap and overall valuation, see 238090 market cap.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | ₩90.18 Billion ≈ $61.11 Million |
-27.55% |
| 2023-12-31 | ₩124.46 Billion ≈ $84.35 Million |
-10.11% |
| 2022-12-31 | ₩138.46 Billion ≈ $93.83 Million |
-14.63% |
| 2021-12-31 | ₩162.19 Billion ≈ $109.91 Million |
+21.77% |
| 2020-12-31 | ₩133.19 Billion ≈ $90.26 Million |
+19.75% |
| 2019-12-31 | ₩111.22 Billion ≈ $75.37 Million |
+31.50% |
| 2018-12-31 | ₩84.58 Billion ≈ $57.32 Million |
+5.05% |
| 2017-12-31 | ₩80.52 Billion ≈ $54.56 Million |
+0.02% |
| 2016-12-31 | ₩80.50 Billion ≈ $54.56 Million |
+229.17% |
| 2015-12-31 | ₩24.46 Billion ≈ $16.57 Million |
+114.04% |
| 2014-12-31 | ₩11.43 Billion ≈ $7.74 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to NDFOS Co. Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 587.0% over the analyzed period, potentially due to dividend distributions or operating losses.
NDFOS Co. Ltd Net Assets Breakdown (December 2024)
NDFOS Co. Ltd net assets breakdown by equity component as of December 2024.
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | ₩12.21 Billion | 13.54% |
| Other Components | ₩104.40 Billion | 115.77% |
| Total Equity | ₩90.18 Billion | 100.00% |
NDFOS Co. Ltd Competitors by Market Cap
The table below lists competitors of NDFOS Co. Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Galaxia SM Inc
KO:011420
|
$21.66 Million |
|
Naos Emerging Opportunities Company Ltd
AU:NCC
|
$21.67 Million |
|
Maheshwari Logistics Limited
NSE:MAHESHWARI
|
$21.67 Million |
|
Country Club Hospitality & Holidays Limited
NSE:CCHHL
|
$21.67 Million |
|
Lung Hwa Electronics Co Ltd
TW:2424
|
$21.65 Million |
|
The Union Mosaic Industry Public Company Limited
BK:UMI
|
$21.64 Million |
|
Niche Capital Emas Holdings
KLSE:7139
|
$21.64 Million |
|
HG Capital Trust PLC
LSE:HGT
|
$21.63 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in NDFOS Co. Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 124,462,750,910 to 90,175,178,460, a change of -34,287,572,450 (-27.5%).
- Net loss of 31,024,523,420 reduced equity.
- Share repurchases of 3,157,778,910 reduced equity.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | ₩-31.02 Billion | -34.4% |
| Share Repurchases | ₩3.16 Billion | -3.5% |
| Other Changes | ₩-105.27 Million | -0.12% |
| Total Change | ₩- | -27.55% |
Book Value vs Market Value Analysis
This analysis compares NDFOS Co. Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.35x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2016-12-31 | ₩5263.32 | ₩1404.00 | x |
| 2017-12-31 | ₩5344.92 | ₩1404.00 | x |
| 2018-12-31 | ₩5108.93 | ₩1404.00 | x |
| 2019-12-31 | ₩5525.03 | ₩1404.00 | x |
| 2020-12-31 | ₩6154.98 | ₩1404.00 | x |
| 2021-12-31 | ₩6998.86 | ₩1404.00 | x |
| 2022-12-31 | ₩5881.57 | ₩1404.00 | x |
| 2023-12-31 | ₩5287.00 | ₩1404.00 | x |
| 2024-12-31 | ₩3961.91 | ₩1404.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently NDFOS Co. Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -34.40%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -59.15%
- • Asset Turnover: 0.50x
- • Equity Multiplier: 1.17x
- Recent ROE (-34.40%) is below the historical average (5.58%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2014 | 35.63% | 8.77% | 1.84x | 2.20x | ₩2.93 Billion |
| 2015 | 56.26% | 23.95% | 1.65x | 1.43x | ₩11.31 Billion |
| 2016 | 18.54% | 21.15% | 0.79x | 1.10x | ₩6.88 Billion |
| 2017 | 10.03% | 15.42% | 0.56x | 1.15x | ₩20.77 Million |
| 2018 | -16.08% | -28.48% | 0.37x | 1.54x | ₩-22.06 Billion |
| 2019 | -0.56% | -0.74% | 0.44x | 1.71x | ₩-11.75 Billion |
| 2020 | 6.17% | 9.22% | 0.51x | 1.31x | ₩-5.11 Billion |
| 2021 | 11.13% | 28.51% | 0.27x | 1.43x | ₩1.83 Billion |
| 2022 | -14.27% | -22.12% | 0.52x | 1.25x | ₩-33.60 Billion |
| 2023 | -11.07% | -28.19% | 0.35x | 1.13x | ₩-26.22 Billion |
| 2024 | -34.40% | -59.15% | 0.50x | 1.17x | ₩-40.04 Billion |
Industry Comparison
This section compares NDFOS Co. Ltd's net assets metrics with peer companies in the Specialty Chemicals industry.
Industry Context
- Industry: Specialty Chemicals
- Average net assets among peers: $1,274,656,998,498
- Average return on equity (ROE) among peers: 3.57%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| NDFOS Co. Ltd (238090) | ₩96.69 Billion | 35.63% | 0.15x | $21.66 Million |
| DL Holdings CO. LTD. (000210) | $5.15 Trillion | 5.16% | 1.41x | $565.25 Million |
| DL Holdings Co Ltd Preferred (000215) | $4.92 Trillion | -1.79% | 1.48x | $22.38 Million |
| Norooholdings (000320) | $660.83 Billion | 3.78% | 0.77x | $96.82 Million |
| Noroo Holdings Co Ltd (000325) | $533.52 Billion | 2.04% | 0.82x | $4.49 Million |
| Samhwa Paint (000390) | $111.40 Billion | 6.40% | 1.03x | $107.63 Million |
| Kangnam Jevisco Co Ltd (000860) | $678.85 Billion | 0.91% | 0.41x | $107.48 Million |
| Paik Kwang Ind (001340) | $120.49 Billion | 1.97% | 1.33x | $126.11 Million |
| Bo Lak (002760) | $46.65 Billion | -3.24% | 0.27x | $39.94 Million |
| Songwon Industrial (004430) | $378.13 Billion | 9.36% | 1.29x | $170.78 Million |
| Cho Kwang Pain (004910) | $150.26 Billion | 11.15% | 0.61x | $20.43 Million |
About NDFOS Co. Ltd
NDFOS Co., Ltd. operates as a tape and film company in South Korea. The company offers adhesive tapes, such as waterproof tapes, light-shielding tapes, heat reaction tapes, battery fixing tapes, thin film tapes, convergence type functional tapes, and heat radiation tapes; functional films, including automobiles, industries, and everyday life. It also develops ARS and STR, anticancer drugs for can… Read more